Adragos Pharma
Halden, Norway
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Adragos Pharma
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Halden, Norway
- Modalities
- BFS plastic vials, Plastic ampoules, IV bags, Sterile ophthalmic, Nasal, Otic injectables
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Adragos Pharma
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBFS plastic vials, Plastic ampoules, IV bags, Sterile ophthalmic, Nasal, Otic injectables
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (6 modalities)
Recent News 10 articles
Adragos Pharma Completes Acquisition of Sanofi’s Sterile Fill-Finish Site in France - CHEManager
Adragos Pharma Acquires Swiss Sterile Fill-Finish Firm Baccinex - Contract Pharma
Fast-growing Adragos snaps up Swiss CDMO Baccinex, significantly expanding fill-finish firepower - Fierce Pharma
Adragos Pharma Strengthens Sterile Manufacturing Capabilities with Baccinex Acquisition - PharmTech.com
On the Rise: CDMO/CMO Expansions for Injectables - DCAT Value Chain Insights
Adragos Pharma Expands Drug-Product Capabilities with Key Acquisitions - DCAT Value Chain Insights
Successful transaction: Adragos Pharma has officially taken over the Sanofi production site in Kawagoe, Japan - Via TT
German CDMO Adragos buys French sterile injectables plant from Sanofi - Fierce Pharma
Adragos Pharma, Prange Group Acquires Fresenius Kabi Plant - Pharmaceutical Commerce
Production site in Northern Europe acquired by Prange Group and Adragos Pharma - Manufacturing Chemist
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in: